Dear Reader,

Welcome to the final issue of Drugs in R&D for 2022.

I wish to reflect on this year’s achievements, and to thank all those who have contributed their time and effort to guarantee the quality of the content published in the journal.

In 2022, over 30 articles have been published. The high quality of content published in Drugs in R&D has been reflected in the most recent Impact Factor of 3.203 and CiteScore™ of 4.3.

I want to thank the authors of the articles published in Drugs in R&D over the course of 2022. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.

The quality of published articles is also testament to the diligence of the peer reviewers. I would like to acknowledge the following individuals who acted as reviewers for Drugs in R&D in the last 12 months:

Stacey Adam, USA

Bogdan Amuzescu, Romania

Alain Astier, France

Oyekoya Ayonrinde, Australia

Gabriela Barrientos, Argentina

Agatha Bastida, Spain

James Bell, UK

Agnieszka Bienert, Poland

Ato Bolek, Slovakia

Arun Butreddy, India

Cherie Butts, USA

Andrea Calvo, Italy

Anna Campello, Italy

Annalisa Campomori, Italy

Enrique Carrazana, USA

Tanju Çelik, Turkey

Jer-Ming Chang, Taiwan, Republic of China

Naveen Chella, India

Iwona Chlebicka, Poland

Magdalena Ciążyńska, Poland

Asim Bikas Das, India

Hans-Christoph Diener, Germany

Zoubir Djerada, France

Nancy A. Dreyer, USA

Noel O. Dybdal, USA

Josef Finsterer, Austria

Ruth Fritsch-Stork, Austria

Spyridon Gkalpakiotis, Czech Republic

Navin Goyal, USA

Stephen Greene, USA

Chelsey Grimbly, Canada

Paul Grootendorst, Canada

Tadeusz W. Hermann, Poland

Jan Hosek, Czech Republic

Dong-Liang Hu, Japan

Simon Hutchings, UK

Ei'Ichi Iizasa, Japan

Monica Jablonski, USA

Andre J. Jackson, USA

Anselm Jorda, Austria

Yasuyuki Kawamoto, Japan

Ryan Knox, USA

Andrew Lassman, USA

Bimal K. Malhotra, USA

Fiona Marra, UK

Catia Marzolini, Switzerland

Sarah A. McGraw, USA

Donovan McGrowder, Jamaica

Margarida Miranda, Portugal

Kenji Momo, Japan

Shigeo Muro, Japan

Natalia Navas, Spain

Deanna Nelson, USA

Przemysław Pączkowski, Poland

Jennifer Patterson, Spain

Frank Petavy, The Netherlands

Dima Qato, USA

Alessandro Rizzo, Italy

Rania Sarhan, Egypt

Sebastian Schloer, Germany

Ray Schuch, USA

Marie L.A. Schuttelaar, The Netherlands

Feng Shao, China

Cristiana Sieiro Santos, Spain

Nuno Silva, Portugal

Lorna Smith, UK

Adina Stan, Romania

Frantisek Stepanek, Czech Republic

Raju Subramanian, USA

Fatemeh Tabatabaie, Islamic Republic of Iran

Dhanusha Thambavita, Sri Lanka

Alberto Traverso, The Netherlands

Jakub Treml, Czech Republic

Malgorzata Trocha, Poland

Periklis Tsiros, Greece

Ruben van Eijk, The Netherlands

Maurits Vissers, The Netherlands

Bruno K. Vitturi, Brazil

Giau Van Vo, Viet Nam

Zhenlei Wang, China

Xiaoyu Yan, Hong Kong, China

Neville Yeomans, Australia

Mark Zimering, USA

I am also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes.

The editorial program for 2023 is well under way, and I am looking forward to bringing you many high-quality and authoritative articles in the field of pharmacology over the coming year.

I thank you for your continued support.

With best wishes,

Anton van Rensburg